Several medical societies supported extending Medicare coverage for TAVR to patients with asymptomatic aortic stenosis, but ...

Edwards pushes CMS to expand Medicare TAVR coverage to asymptomatic patients, sparking controversy among physicians over ...

NEW ORLEANS, LA—A risk model based on data from the Society of Thoracic Surgeons (STS) Adult Cardiac Surgery Database (ACSD) ...

Pulsed-field ablation, transcatheter heart valves, and IVL are among the top stories, as they drive growth among the largest ...

St. Luke’s Medical Center - Global City marks a significant milestone for its cardiovascular services, having successfully ...

Edwards Lifesciences Corporation (NYSE:EW) is one of the best healthcare stocks to buy for 2026. On January 20, Stifel raised ...

Medtronic’s investment is contingent on Anteris completing a proposed $200 million public stock offering.

At 95 years old, Ventura Latorre was running out of time as severe aortic stenosis pushed him into repeated hospitalizations ...

While many people fear a cancer diagnosis above all else, clinical data reveals that symptomatic aortic stenosis, a severe ...

Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ: AVR, ASX: AVR) a global structural heart company committed to designing, developing, and commercializing cutting-edge medical ...

Chris Waddell, a leader for the heart valve replacement business at Abbott, announced on social media that he is leaving the company.

Edwards Lifesciences Corp. faced a legal loss early this month that forced it to call off its $945 million acquisition of ...